보조금National Institutes of Health

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

이 공고에 대해

National Institutes of Health · Instrument: cooperative_agreement · Category: health

출처

이 정보의 출처는 grants.gov입니다. 지원하기 전에 그곳에서 자격과 마감일을 확인하세요.

Source: Grants.gov. This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services.